Eurohold Bulgaria AD (BUL:EUBG)

Verve Therapeutics Ratios and Metrics

Market cap in millions BGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	482	518	443	469	616	340
Market Cap Growth	50.00%	17.06%	-5.56%	-23.94%	81.03%	-0.84%
Enterprise Value	1,363	1,368	1,026	1,218	1,500	443
Last Close Price	1.85	1.99	1.70	1.80	2.46	1.74
PE Ratio	18.24	15.32	5.73	-	13.15	-
PS Ratio	0.16	0.19	0.16	0.12	0.32	0.22
PB Ratio	1.55	1.92	3.54	9.09	1.66	2.52
P/TBV Ratio	6.21	18.83	-	-	-	-
P/FCF Ratio	-	234.18	1.44	2.49	-	-
P/OCF Ratio	4.44	4.05	1.08	1.55	-	-
EV/Sales Ratio	0.45	0.49	0.37	0.30	0.79	0.28
EV/EBITDA Ratio	4.63	4.76	5.26	5.36	15.91	-
EV/EBIT Ratio	7.65	7.27	10.28	9.38	29.05	-
EV/FCF Ratio	-41.22	617.94	3.33	6.46	-	-
Debt / Equity Ratio	4.91	5.45	10.65	27.62	3.56	3.51
Debt / EBITDA Ratio	5.25	4.87	6.37	5.79	13.18	605.52
Debt / FCF Ratio	-	665.17	4.33	7.55	-	-
Asset Turnover	1.12	1.07	1.12	1.29	0.70	1.01
Inventory Turnover	85.45	77.86	81.21	108.12	56.01	43.85
Quick Ratio	1.98	2.14	1.59	1.53	1.56	0.54
Current Ratio	2.26	2.23	1.64	1.60	1.62	0.57
Return on Equity (ROE)	10.66%	16.78%	-48.91%	6.27%	-3.94%	-26.74%
Return on Assets (ROA)	4.04%	4.50%	2.52%	2.59%	1.19%	-0.77%
Return on Capital (ROIC)	6.47%	7.35%	4.25%	5.13%	2.81%	-2.03%
Return on Capital Employed (ROCE)	7.60%	8.50%	5.50%	7.00%	1.70%	-
Earnings Yield	5.71%	6.53%	17.45%	-36.27%	7.61%	-12.87%
FCF Yield	-6.86%	0.43%	69.50%	40.25%	-16.94%	-2.76%
Payout Ratio	-	-	-	-	2.62%	-
Buyback Yield / Dilution	-	-	-	-14.49%	-15.22%	-0.64%
Total Shareholder Return	-	-	-	-14.49%	-15.22%	-0.64%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.